[Randomized placebo trial of myeloprotection with goralatide in patients with squamous cell carcinoma of the upper respiratory and digestive tracts or esophagus, treated with a carboplatin-fluorouracil combination].P Cappelaere, Patrice Carde, C. Domenge et al.|PubMed|1995Cited by 4
[Predictive value of the hemogram for myelotoxicity induced by the association of carboplatin-fluorouracil on the 4th day of the therapeutic regimen].P Cappelaere, B Hecquet, C. Fournier et al.|PubMed|1996Cited by 0